CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $8.49B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.54: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.85%
Annual Rate
USD 0.35Paid unknown
Payout Ratio
13.4%Sustainable
Paying Dividends
3 yr
Last Ex-Dividend
Jul 7, 2026
Last Payment
Jul 14, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.49BUSDvs all stocks (USD)
Trailing P/E
20.99xvs Diagnostics & Research peers
Revenue (TTM)
2.10BUSDvs all stocks (USD)
Profit Margin
19.16%vs Diagnostics & Research peers
Beta
0.6430xvs all stocks
52-Week Change
-14.38%vs all stocks
Forward Annual Dividend Yield
0.85%vs all stocks
Market Capitalization
8.49BUSDvs all stocks (USD)
Enterprise Value
9.51BUSDvs all stocks (USD)
Trailing P/E
20.99xvs Diagnostics & Research peers
Forward P/E
15.69xvs Diagnostics & Research peers
PEG Ratio
-0.8280xvs Diagnostics & Research peers
Price to Sales (TTM)
4.04xvs Diagnostics & Research peers
Price to Book (MRQ)
2.55xvs Diagnostics & Research peers
Enterprise to Revenue
4.53xvs Diagnostics & Research peers
Enterprise to EBITDA
13.07xvs Diagnostics & Research peers
Gross Margin
62.89%vs Diagnostics & Research peers
Profit Margin
19.16%vs Diagnostics & Research peers
Operating Margin
23.82%vs Diagnostics & Research peers
Return on Assets (TTM)
6.01%vs Diagnostics & Research peers
Return on Equity (TTM)
11.93%vs Diagnostics & Research peers
Revenue (TTM)
2.10BUSDvs all stocks (USD)
Revenue per Share (TTM)
10.18USDUpdated Jul 19, 2026Quarterly Revenue Growth
1.80%vs Diagnostics & Research peers
Gross Profit (TTM)
1.39BUSDvs all stocks (USD)
EBITDA (TTM)
774.05MUSDvs all stocks (USD)
Net Income (TTM)
402.16MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-25.00%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
615.21MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
238.87MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.3500USDUpdated Jul 19, 2026Forward Annual Dividend Yield
0.85%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
13.41%vs Diagnostics & Research peers
Revenue
2.09BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
790.50MUSDFY2025 · Dec 31, 2025Gross Profit
1.30BUSDFY2025 · Dec 31, 2025Operating Income
520.31MUSDvs all stocks (USD)
Pre-tax Income
490.26MUSDFY2025 · Dec 31, 2025Income Tax Expense
65.39MUSDFY2025 · Dec 31, 2025Net Income
424.88MUSDFY2025 · Dec 31, 2025EBIT
523.52MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
771.73MUSDFY2025 · Dec 31, 2025Research & Development
187.52MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
583.67MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
64.32MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
33.26MUSDFY2025 · Dec 31, 2025EPS (Basic)
2.06USDFY2025 · Dec 31, 2025EPS (Diluted)
2.04USDFY2025 · Dec 31, 2025Basic Shares Outstanding
206.07MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
206.07MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
424.88MUSDFY2025 · Dec 31, 2025Operating Cash Flow
670.72MUSDFY2025 · Dec 31, 2025Free Cash Flow
469.67MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
839.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
17.27MUSDFY2025 · Dec 31, 2025Interest Paid
29.25MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
424.88MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
193.75MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-20.07MUSDFY2025 · Dec 31, 2025Stock-based Compensation
50.40MUSDFY2025 · Dec 31, 2025Other Non-cash Items
16.47MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-36.39MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-8.42MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
50.10MUSDFY2025 · Dec 31, 2025Capital Expenditures
-201.05MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-6.08MUSDFY2025 · Dec 31, 2025Net Acquisitions
-291.23MUSDFY2025 · Dec 31, 2025Purchase of Investments
-371.82MUSDFY2025 · Dec 31, 2025Sale of Investments
597.06MUSDFY2025 · Dec 31, 2025Other Investing Activity
-32.16MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-299.20MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
742.32MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-534.17MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-54.24MUSDFY2025 · Dec 31, 2025Other Financing Charges
-332.88MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-178.98MUSDFY2025 · Dec 31, 2025Shares Outstanding
206.25MSharesUpdated Jul 19, 2026Float Shares
204.78MSharesUpdated Jul 19, 2026Shares Short
6.61MSharesUpdated Jul 19, 2026Short Ratio
2.64daysvs all stocks
Short % of Shares Outstanding
3.63%vs all stocks
% Held by Insiders
0.47%vs all stocks
% Held by Institutions
81.59%vs all stocks
Total Cash (MRQ)
646.29MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.13USDUpdated Jul 19, 2026Total Debt (MRQ)
1.67BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.5004xvs Diagnostics & Research peers
Current Ratio (MRQ)
3.21xvs Diagnostics & Research peers
Book Value per Share (MRQ)
16.15USDUpdated Jul 19, 2026Total Assets
6.28BUSDvs all stocks (USD)
Total Current Assets
2.00BUSDFY2025 · Dec 31, 2025Total Liabilities
2.50BUSDFY2025 · Dec 31, 2025Total Non-current Assets
4.29BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.99BUSDFY2025 · Dec 31, 2025Total Current Liabilities
512.14MUSDFY2025 · Dec 31, 2025Cash
136.54MUSDFY2025 · Dec 31, 2025Cash Equivalents
702.46MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
839.00MUSDFY2025 · Dec 31, 2025Other Short-term Investments
259.91MUSDFY2025 · Dec 31, 2025Accounts Receivable
402.61MUSDFY2025 · Dec 31, 2025Inventory
301.89MUSDFY2025 · Dec 31, 2025Accounts Payable
72.66MUSDFY2025 · Dec 31, 2025Short-term Debt
28.84MUSDFY2025 · Dec 31, 2025Deferred Revenue
79.42MUSDFY2025 · Dec 31, 2025Other Current Liabilities
94.25MUSDFY2025 · Dec 31, 2025Long-term Debt
1.78BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
207.41MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.53MUSDFY2025 · Dec 31, 2025Retained Earnings
2.75BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
3.78BUSDvs all stocks (USD)
Treasury Stock
31.82MUSDFY2025 · Dec 31, 202552-Week Low
32.53USDUpdated Jul 19, 202652-Week High
57.82USDUpdated Jul 19, 202652-Week Change
-14.38%vs all stocks
Beta
0.6430xvs all stocks
50-Day MA
37.10USDUpdated Jul 19, 2026200-Day MA
43.40USDUpdated Jul 19, 2026Avg 10-Day Volume
3.79MSharesUpdated Jul 19, 2026Avg 30-Day Volume
2.93MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
1.96USDUpdated Jul 19, 2026Other Income / Expense
-61.11MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.54: safe zoneNotable
Altman Z-Score: 3.54
High earnings qualityNotable
Earnings Quality Score: 0.61
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $8.49B, above the global median of $1.15BNotable
Market cap (USD): 8,487,187,500Global Median: 1,146,734,693.424
Revenue is $2.1B, above the global median of $520.53MNotable
Revenue (USD): 2,098,862,976Global Median: 520,528,949.311
Levered free cash flow is $238.87M, above the global median of $16.24MNotable
Levered free cash flow (USD): 238,874,368Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
thyssenkrupp AG
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Nantong Jianghai Capacitor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
AptarGroup, Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Alstom SA
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang JingSheng Mechanical & Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Hualu Hengsheng Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shenzhen Fastprint Circuit Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Etern Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Haohua Chemical Science Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Zhejiang Chint Electrics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
2 interpretationsCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin Elevated
Suzhou Sepax Technologies Inc.
2 interpretationsCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin Elevated
Concord Biotech Ltd.
2 interpretationsCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin Elevated